InChI=1S/C15H17FN4O3/c1-2-19-8-10(15(22)23)12(21)9-7-11(16)14(18-13(9)19)20-5-3-17-4-6-20/h7-8,17H,2-6H2,1H3,(H,22,23) |
IDYZIJYBMGIQMJ-UHFFFAOYSA-N |
CCn1cc(C(O)=O)c(=O)c2cc(F)c(nc12)N1CCNCC1 |
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
antibacterial drug
A drug used to treat or prevent bacterial infections.
DNA synthesis inhibitor
Any substance that inhibits the synthesis of DNA.
antimicrobial agent
A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans.
(via quinolone antibiotic )
(via heterocyclic antibiotic )
(via fluoroquinolone antibiotic )
|
|
antibacterial drug
A drug used to treat or prevent bacterial infections.
|
|
View more via ChEBI Ontology
1-ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
|
enoxacin
|
ChemIDplus
|
enoxacine
|
ChemIDplus
|
enoxacino
|
ChemIDplus
|
enoxacinum
|
ChemIDplus
|
1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic acid
|
ChemIDplus
|
1-Ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid
|
ChEMBL
|
Enoxacin
|
KEGG COMPOUND
|
ENOXACIN
|
ChEMBL
|
1013
|
DrugCentral
|
1896
|
VSDB
|
C06979
|
KEGG COMPOUND
|
D00310
|
KEGG DRUG
|
DB00467
|
DrugBank
|
Enoxacin
|
Wikipedia
|
EP9425
|
Patent
|
LSM-5848
|
LINCS
|
US4352803
|
Patent
|
US4359578
|
Patent
|
View more database links |
3628995
|
Reaxys Registry Number
|
Reaxys
|
74011-58-8
|
CAS Registry Number
|
KEGG COMPOUND
|
74011-58-8
|
CAS Registry Number
|
ChemIDplus
|
16644219
|
PubMed citation
|
ChEMBL
|
8741236
|
PubMed citation
|
Europe PMC
|
|